The World Health Organization (WHO) will examine international cannabis laws this week during the 40th meeting of the Expert Committee on Drug Dependence. WHO called the specially convened sessions in Geneva, Switzerland to review the medicinal benefits of cannabis and cannabis related substances including: the cannabis plant and cananbis resin, extracts and tinctures of cannabis, Delta-9-tetrahydrocannabinol (THC), and Isomers of THC.
The World Health Organization declared that Cannabidiol (CBD), a cannabinoid that can be derived from cannabis and industrial hemp, is non-addictive and contains a number of medicinal applications including the treatment of diseases such as epilepsy. Now the international agency is taking a long look at the cannabis plant as a whole, including its psychoactive component THC.
A number of countries and U.S. states have recently approved the recreational and medicinal uses of cannabis and the pre-preview documents being reviewed by the committee contains a complete breakdown based on pharmacology, toxicology, m and the therapeutic uses of the plant.
If the committee accepts the pre-review, WHO could order a comprehensive and complete examination of the medicinal benefits of the cannabis plant. In turn this could eventually lead to Who changing international cannabis laws.